← Open Payments lookup

CHRISTINE CORALLINO: Open Payments

NPI 1366961310 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,836 in 86 payments from 21 companies in 2025. Trend: 2023 $1,174 · 2024 $697 · 2025 $1,836

Food & beverage: $1,836
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.9$254
ABBVIE INC.15$217
Janssen Biotech, Inc.11$204
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$151
QOL Medical, LLC4$132
Madrigal Pharmaceuticals3$122
Gilead Sciences, Inc.4$107
GENZYME CORPORATION3$87
Phathom Pharmaceuticals, Inc.5$84
Novo Nordisk Inc4$77

Products named: ENTYVIO, TREMFYA, XIFAXAN, Sucraid, REZDIFFRA, DUPIXENT, RINVOQ, VOQUEZNA.

Industry payments across MA — which companies pay providers there.